With that being reported, with out human trials there's no way to really evaluate simply how much YK11 can inhibit Myostatin in humans (if in the least), and when there is a dosage that might equate to a similar amount of Myostatin inhibition that a genetic anomaly which has a gene mutation has.At the end of the eight 7 days cure period the animals